Persisters are phenotypic variants present within isogenic bacterial populations that exhibit extreme tolerance toward antibiotic stress. We previously elucidated a mechanistic pathway by which Escherichia coli persisters to ofloxacin form in response to a carbon source transition. Here, we examine how persisters to ampicillin form from the same metabolic stress and identify the shared and unique elements of the persister formation pathways. We discovered that diauxie-dependent formation of ampicillin persisters required RelA and that loss of clpA, ssrA, or smpB eliminated persister formation through relaxation of the stringent response. Further, we found that tolerance to ampicillin was achieved through broad inhibition of peptidoglycan biosynthesis, as evidenced by the formation of persisters to antibiotics that target enzymes in different areas of that biosynthetic pathway. Interestingly, ppGpp was required for formation of both ampicillin and ofloxacin persisters, and we demonstrated that higher synthesis of the alarmone was needed to increase persisters to ampicillin compared to ofloxacin. Further, we found trans-translation and DksA to be common mediators of both pathways, whereas ClpA was unique for ampicillin persisters and nucleoid-associated proteins were unique for ofloxacin persisters. These results highlight the need to consider an antibiotic's mode of action when analyzing persister formation, demonstrate that individual stresses can produce persister heterogeneity, and emphasize the importance of identifying each respective pathway to identify common mediators that possess the most therapeutic potential to combat persisters.
INTRODUCTION
Persisters comprise a transient phenotypic subpopulation of bacterial cultures that exhibits tolerance to supra-lethal concentrations of antibiotics. Persisters are distinct from antibioticresistant cells in that there is no genetic mutation allowing them to proliferate in the presence of antibiotics, but rather they exist in a favorable phenotypic state at the time of treatment that allows survival [1] . Persisters have been implicated in chronic infections and are believed to be responsible for the recalcitrance of biofilm infections [1] .
Persister tolerances have mainly been attributed to entry into a non-growing physiological state where essential targets that antibiotics corrupt are inactive. Supportive evidence for this mechanism originated from single-cell microfluidic studies where non-or slow-growing cells survived treatment [2, 3] . According to this model, persisters should exhibit multidrug tolerance and possess largely uniform antibiotic susceptibility [1, 4] . However, when identical cultures are treated with different antibiotics, it is not uncommon to observe different persister levels [5] [6] [7] [8] [9] . For example, Vega and colleagues showed that higher indole concentrations increased persisters to different classes of antibiotics to varying degrees [9] . Therefore, persister populations should be regarded as heterogeneous [3, 4, 6, 10, 11] , where single-cell variability in cellular processes generates physiological diversity. Identification of mechanisms responsible for this drug-specific heterogeneity will provide knowledge of common mediators that can be used to broadly impair persister formation.
We previously discovered an ofloxacin persister formation pathway triggered by a carbon source transition, where the metabolic TA module, ppGpp-SpoT, DksA, and nucleoidassociated proteins (NAPs) were required for fluoroquinolone tolerance [12] . We also showed that carbon source transitions stimulated ampicillin persister formation, but the initial results suggested that distinct formation mechanisms were responsible for ampicillin and ofloxacin persisters. Here, we elucidated the ampicillin persister formation pathway by studying diauxic batch growth of E. coli and using genetic perturbations, metabolite quantification, quantitative PCR (qPCR), and biochemical assays. We linked glucose exhaustion to a stringent response that required RelA, trans-translation, and ClpA to broadly inhibit peptidoglycan biosynthesis (PGB), which contains ampicillin's primary target. We found ppGpp to be an important mediator of both ofloxacin and ampicillin persister formation and demonstrated that tolerance to these different antibiotics was engendered by different ppGpp levels. With these results, we provided evidence that a single metabolic stress triggered antibiotic-specific persister formation pathways and identified common mediators that could be utilized as targets to inhibit those processes.
RESULTS

Diauxic Shifts Stimulate Ampicillin Persister Formation
We have previously shown that carbon source shifts from glucose to a variety of secondary carbon sources stimulated ofloxacin and ampicillin persister formation [12] . Interestingly, we observed that all diauxic transitions stimulated ofloxacin persister formation, whereas ampicillin persister formation was not observed in certain diauxic conditions, which suggested that the formation pathways were different. Previously, we elucidated the ofloxacin persister formation pathway [12] , whereas, here, we sought to identify how diauxie generated ampicillin persisters. We focused on diauxic growth from glucose to fumarate since it elicited the strongest persister formation response, and we used growth on glucose as the sole carbon source and growth on glucose to fructose, which is non-diauxic and not co-utilized with glucose, as controls [12] . Persister measurements were taken during growth on glucose (0.02 optical density 600 [OD 600 ]) and after glucose exhaustion and growth on the secondary substrate, except for the sole glucose control that grew on glucose throughout (0.12 OD 600 ) (Table S1 ). During growth on glucose, persister levels were the same independent of the secondary carbon source present ( Figure 1A ). Persister measurements during growth on the secondary carbon source showed a statistically significant 25-fold increase in persisters for glucose-fumarate cultures and no increase for glucose-fructose cultures when compared to persister levels in glucose-only cultures at the same OD 600 .
To establish that persister formation was due to the transition from glucose to fumarate and not from slower growth on fumarate, we took persister measurements at the same cell densities during growth on sole fumarate ( Figure 1B) . The persister levels for the fumarate-only cultures were comparable to persister levels for glucose-only cultures but were 75-fold lower and statistically different from those for the glucose-fumarate cultures. These results demonstrated that the persister formation was (C) Cells grown in glucose-fumarate were treated with either ampicillin, ofloxacin, or co-treated. Cotreatment had significantly fewer persisters than either sole treatment. Error bars indicate SEM. Significance was assessed using the null hypothesis that the mean CFU/mL in two samples was equal. See also Table S1 .
the result of the carbon source transition and not due to growth on fumarate.
We next examined whether the ampicillin and ofloxacin persisters formed originated from a single multidrugtolerant population by co-treating cultures. We observed that prior to the transition, persister levels were all comparable, whereas after the transition, the co-treated persister population was significantly reduced 10-fold compared to the persister populations in the sole treatments ( Figure 1C ). This suggested that the majority of ampicillin and ofloxacin persisters formed from the transition (90%) were in independent subpopulations where they were tolerant to one antibiotic but not the other. Further, these data provided additional support that separate mechanisms existed for ampicillin and ofloxacin persister formation from this metabolic stress.
Addition of cAMP and Serine Hydroxamate Stimulate Ampicillin Persister Formation
We next evaluated the roles of diauxie mediators in ampicillin persister formation. The two major signaling pathways activated during glucose limitation, catabolite de-repression and stringent response activation [13] , cannot be eliminated in our growth conditions [12] since DcyaA and Dcrp prevent resumption of growth on the secondary carbon source, and DrelADspoT and DdksA are auxotrophic [13] . Therefore, we tested how synthetically increasing levels of cyclic AMP (cAMP) and ppGpp affect ampicillin persister formation.
Addition of cAMP generated a statistically significant 10-fold increase in persisters when compared to the untreated wildtype culture (Figure 2A) . In a Dcrp mutant, addition of cAMP failed to increase persister levels, which suggested that cAMP-CRP has the ability to signal ampicillin persister formation ( Figure 2B ). However, we note that Dcrp persister levels in our untreated control were higher than those of wild-type, which could have masked modest induction of persistence from cAMP. Notably, though, we did not observe a growth defect upon cAMP addition to Dcrp as we did for wild-type (Figure S1A) . Collectively, these data suggest that cAMP broadly impacts wild-type physiology, including persistence, whereas the same cannot be said for Dcrp. We previously discovered cAMP-triggered formation of ofloxacin persisters was eliminated in DrelADspoT [12] , but testing this mutant requires amino acid (aa) supplementation, and in media with aa, we observed no ampicillin persister formation in response to cAMP (Figure S1B ). However, we tested DrelA, which does not require aa supplementation, and observed that persister formation was eliminated in response to cAMP ( Figure 2C ), suggesting a role for ppGpp in ampicillin persister formation downstream of cAMP-CRP.
We investigated whether ppGpp, independent of cAMP-CRP, can stimulate ampicillin persister formation with the use of serine hydroxamate (SHX), which rapidly increases ppGpp [14] . Since SHX results in growth arrest ( Figure S1C ), which may increase antibiotic tolerance [12, 15] , as a control we used chloramphenicol (CAM) since it is also bacteriostatic but does not increase ppGpp [16] (Figure S1C ). SHX generated a statistically significant 14-fold increase in ampicillin persisters, whereas CAM failed to stimulate persister formation ( Figure 2D ). These results demonstrated that increased ppGpp levels induced ampicillin persister formation, whereas bacteriostatic inhibition of translation was insufficient. This contrasts with ofloxacin persister formation under analogous conditions where bacteriostatic inhibition of translation was sufficient to stimulate 100-fold increase in persisters and SHX increased persisters independent of ppGpp [12] . Since the stringent response has been shown to affect the cAMP-CRP regulon [13] , we tested whether SHX-mediated ampicillin persister formation was cAMP dependent but found that SHX formed as many persisters in DcyaA as wild-type ( Figure S1D ). Unlike ofloxacin persister formation where two pathways existed, cAMP-ppGpp dependent and growth-arrest dependent [12] , data presented here suggested the existence of only one ampicillin pathway. (D) Persistence to ampicillin of wild-type exposed to 1 mg/mL SHX, 50 mg/mL CAM, or no treatment. Error bars indicate SEM. Significance was assessed using the null hypothesis that the mean CFU/mL in two samples was equal. See also Figure S1 .
Stringent Response at the Carbon Transition Is Required for Persister Formation
The results from the small molecule studies guided us to analyze how SHX triggered persister formation and to apply this knowledge to further understand the diauxie-dependent pathway. SHX inhibits tRNA
Ser aminoacylation causing an accumulation of uncharged tRNA Ser and activation of RelA-dependent ppGpp synthesis [14] . Given this and that RelA contributes to the stringent response during diauxie [13] , we measured persisters prior to and after glucose exhaustion for DrelA, which removed persister formation ( Figure 3A ). The complemented DrelA strain restored persister formation ( Figure S2C ), confirming that RelA is required for ampicillin persister formation.
In addition to stimulating the stringent response [14] , SHX treatment results in translational stalling and activation of trans-translation [17] . Trans-translation is a quality control mechanism that requires SsrA and SmpB and is activated under several stresses including aa and glucose starvation [18] . Consequently, we measured persisters prior to and after glucose exhaustion for DssrA and DsmpB, which both removed persister formation ( Figures 3B and 3C ). The complemented DssrA and DsmpB strains restored persister formation (Figures S2E and S2G), confirming that trans-translation is required for ampicillin persister formation.
Trans-translation is responsible for clearing stalled ribosomes as well as tagging nascent polypeptides for degradation. Therefore, we wanted to assess these roles using the ssrA-DD allele, where stalled ribosomes are cleared but tagged proteins are unable to interact or be degraded by proteases [19] . When DssrA carrying a plasmid expressing ssrA-DD under its natural promoter was tested, no persister formation was observed (Figure S2H ). These data suggested that the capability to clear stalled ribosomes is not enough to elicit ampicillin persister formation and that degradation of tagged proteins and/or their interaction with proteases may be important. In E. coli, ClpAP and ClpXP are the most prominent and extensively studied SsrA-degrading proteases [19] . Loss of the proteolytic subunit ClpP (DclpP) or the chaperone subunit ClpX (DclpX) exhibited an increase in persisters that was comparable to wild-type (Figures 3D and 3E) . Interestingly, removal of the chaperone subunit ClpA (DclpA) eliminated persister formation ( Figure 3F ). The complemented DclpA strain restored formation ( Figure S2J ), suggesting that although ClpA is required for ampicillin persister formation, it is not due to ClpAP activity since DclpP did not remove formation.
Lon can also degrade SsrA-tagged proteins [20] and has been implicated in persistence through degradation of antitoxins [2, 21] . We tested Dlon in our diauxic media and found that it could not resume growth on fumarate after glucose exhaustion ( Figure S2K ), which prevented assessment of the role of Lon in our pathway. Single deletion strains of 11 toxins exhibited persister formation that was indistinguishable from wild-type ( Figures S2L-S2V) , and DppkDppx, which removes an essential component of the Lon-TA pathway [2] , failed to exhibit diauxie due to co-utilization of glucose and fumarate ( Figure S2W ).
Collectively, these data demonstrate that none of the most likely TA modules are solely responsible for ampicillin persister formation, which, we note, does not exclude the possibility that a combination of toxins could be participating in the pathway described here.
With RelA, trans-translation, and ClpA identified as pathway participants, we sought to determine their interdependence. Since ppGpp regulates the stringent response and is an important mediator of persistence [2, 12, [22] [23] [24] , we tested whether trans-translation and ClpA contribute to persister formation through the stringent response. We measured intracellular ppGpp at the carbon source transition for wild-type, mutants that significantly perturbed our pathway, and DclpX as a control. We established that wild-type ppGpp levels increased 4-fold during the transition compared to ppGpp levels when cells were growing exponentially on glucose ( Figures S3A-S3G) , which is similar to increases in ppGpp reported for glucose-succinate diauxie [25] . At the start of the transition, we found significantly lower ppGpp levels for DrelA and DssrA, whereas DclpA and DclpX possessed analogous concentrations compared to wild-type ( Figures 3G and S3H) . DrelA was expectedly deficient in ppGpp production as RelA is a ppGpp synthase, and this relaxed response during diauxie has been shown previously [25] . Interestingly, DssrA also affected ppGpp synthesis during the carbon source transition, suggesting a role for trans-translation in the stringent response. To measure stringent transcriptional control, we monitored levels of 23S rRNA at the carbon source transition using qPCR [26] . When levels of ppGpp are high, transcription of rRNA is repressed in a strain with an intact stringent response, whereas levels of rRNA will be 2-to 10-fold higher in strains with impaired stringent responses [27, 28] . We found that 23S rRNA expression was >2-fold higher and statistically different in DrelA, DssrA, and DclpA than wild-type at the (D-F) DclpP (D) and DclpX (E) exhibited similar persister formation to wild-type, whereas DclpA (F) eliminated persister formation. Significance was assessed using the null hypothesis that the mutant mean fold change in persisters was equal to the wild-type fold change in persisters. (G) ppGpp in wild-type, DrelA, DssrA, DclpA, and DclpX at the transition. DrelA and DssrA showed statistically significant lower ppGpp than wild-type, whereas ppGpp in DclpA and DclpX was indistinguishable from that of wild-type. (H) DrelA, DssrA, and DclpA showed statistically significant 2-fold higher rRNA expression than wild-type, whereas DclpX rRNA was comparable to wild-type. Significance was assessed using the null hypothesis that the mean fold change of mutant to wild-type was equal to 1. Error bars indicate SEM. See also Figures S2 and S3 and Table S1. start of the transition, whereas DclpX showed 23S rRNA expression comparable to wild-type ( Figures 3H and S3I) . These results indicated that deletion of trans-translation or ClpA leads to relaxed stringent control at the transition similar to cells without RelA and that although ClpA does not alter ppGpp levels during diauxie, it does play a role in transcriptional stringent control.
To further examine connections between trans-translation, ClpA, and RelA, we used expression of the constitutively active relA 0 [29] in DssrA, DsmpB, and DclpA to determine whether increasing ppGpp could restore persister formation. We relied on promoter leakiness to express relA 0 since this expression level was able to complement the DrelA phenotype to that of wild-type carrying an empty vector ( Figures S3J and S3K) . We found that relA 0 expression in DssrA and DsmpB restored persister formation to levels comparable to that of wild-type, which further supported that trans-translation acted through ppGpp to form persisters ( Figures S3L and S3M ). For DclpA expressing relA 0 , persister formation was partially restored (Figure S3N) . We also tested whether clpA overexpression could restore persister levels in DrelA and found that it was unable to do so ( Figures S3O and S3P) . Together with the data presented in Figure 3 , these results suggest that ppGpp is necessary but insufficient for stringent inhibition of rRNA synthesis and that loss of the effect of ClpA on rRNA expression can be compensated for by higher levels of ppGpp.
As stringent transcriptional control uses DksA in addition to ppGpp to more effectively modulate RNAP activity [30] , we tested whether DksA played a role in how ClpA affects the stringent response. Since DksA is a known substrate of ClpXP [31] , we hypothesized that ClpA loss could enhance DksA degradation by ClpXP because ClpX would no longer have to compete with ClpA for ClpP, which would lead to attenuated stringent transcriptional control [30] . We expressed dksA off its natural promoter to increase dksA expression levels in DrelA and DclpA. When persister levels were enumerated, complemented DdksA exhibited persister formation comparable to wild-type with a control vector, and increased levels of DksA in DrelA could not restore persister formation ( Figures S3Q and S3R) , which demonstrated that ppGpp was required for persister formation. For DclpA, dksA overexpression partially restored persister formation ( Figure S3S ) to levels that were analogous to expressing relA 0 in DclpA. This further confirmed ClpA's involvement in stringent transcriptional control and implicated DksA as an important mediator of our pathway. To provide further support for a mechanism where the impact of DclpA depends on the activity of ClpXP, we tested whether DclpP or DclpX would restore persister formation to DclpA. For DclpADclpP and DclpADclpX, we found persister formation comparable to that of wild-type, which provided support that the Clp system impacted persister formation through DksA (Figures S3T and S3U) . Interestingly, these data demonstrate that DrelA, DssrA, and DclpA eliminated persister formation through a common mechanism of an attenuated stringent response.
Stringent Response Leads to Ampicillin Persistence through Broad Shutdown of Peptidoglycan Biosynthesis
Given the essentiality of RelA and the impact of trans-translation and ClpA on stringent control during diauxie, we sought to identify how the stringent response can affect ampicillin's primary target, the penicillin-binding proteins (PBPs) [32] , which are essential enzymes of PGB. Previously, ppGpp was found to inhibit phospholipid synthesis at the site of PlsB, which led to PGB inhibition and ampicillin tolerance [33] . Overexpression of plsB restored ampicillin sensitivity under those conditions [16] ; however, plsB overexpression here exhibited persister formation that was comparable to overexpression of the control protein, GFP ( Figure S4 ).
Beyond inhibition of phospholipid biosynthesis, many studies have linked the stringent response to various aspects of PGB [34] [35] [36] [37] . With a plethora of mechanisms through which the stringent response can perturb PGB, we tested whether persistence to fosfomycin, an inhibitor of the initial step of PGB (MurA) [38] , also increased upon carbon source transitions. If the transition-dependent stringent response was leading to a broad inhibition of PGB, then persisters to antibiotics targeting elements at both the beginning (MurA) and end (PBPs) of the pathway would form persisters in a RelA-dependent manner. In addition, we tested carbenicillin, a b-lactam that targets multiple PBPs, and cefsulodin, a cephalosporin that targets PBP1 [32] . Wildtype cells treated with fosfomycin, carbenicillin, or cefsulodin exhibited 20-fold increases in persisters from the carbon source transition, which were comparable to those observed for ampicillin-treated cells (Figures 4A-4C ). When DrelA was treated with fosfomycin, carbenicillin, or cefsulodin, persister formation was not observed, which was analogous to results with ampicillin ( Figures 4D-4F ). We then studied persister formation when treating with both ampicillin and fosfomycin to inhibit the beginning and end of PGB simultaneously. Since fosfomycin produced lower absolute persister levels than ampicillin under all conditions ( Figures 4A and 4D) , we expected that the co-treatment would yield persister levels identical to fosfomycin treatment if the stringent response broadly inhibited PGB, whereas if heterogeneous inhibition was present, the co-treatment would yield persister levels far below that of the most potent single treatment. In co-treated samples, persister formation was equivalent to that with fosfomycin ( Figure 4G ). These data provide evidence that the diauxie-initiated stringent response facilitates formation of persisters to cell-wall targeting antibiotics through broad inhibition of PGB.
A Single Metabolic Stress Generates Persister Heterogeneity
We elucidated two antibiotic-specific persister formation pathways originating from a single stress and next sought to identify which components overlapped and which were distinct. Ofloxacin persister formation was mediated by RelA, SpoT, DksA, and NAPs, whereas ampicillin persister formation required RelA, trans-translation, and ClpA through a mechanism that involved DksA. RelA-dependent ppGpp synthesis was important for both formation pathways, but its role was more significant in ampicillin persister formation. Since removing one ppGpp synthase, RelA, can eliminate ampicillin persister formation, whereas removal of both RelA and SpoT are needed to eliminate ofloxacin formation, we hypothesized that higher ppGpp concentrations are needed to generate ampicillin persisters. To test this hypothesis, we used controlled expression of relA 0 under an IPTG-inducible promoter to vary levels of ppGpp production. We confirmed that intracellular ppGpp levels increased according to the level of induction of relA 0 ( Figures S5A and S5B ). Upon mild induction of relA 0 (25 mM IPTG), no persister formation for either antibiotic was observed compared to the uninduced control. Upon increasing the inducer concentration, we observed antibiotic-specific persister formation (Figures 5 and  S5C ). For ofloxacin, from 25 mM to 100 mM IPTG, persister levels increased by 600-fold, and those levels were maintained at higher IPTG levels, which resembled switch-like, thresholdbased behavior. For ampicillin, persister levels gradually increased from 25 mM to 1,000 mM IPTG. These results demonstrate that ppGpp can produce unique levels of antibiotic tolerance, which is a distinction likely due to its differential impact on cellular physiology and ultimately the antibiotics' primary targets.
We also sought to genetically test whether ofloxacin mediators participate in the ampicillin pathway and vice versa. Deletion of NAPs, Dfis and DhupB, which were identified as mediators of ofloxacin persister formation [12] , showed ampicillin persister formation analogous to wild-type ( Figures 6A and 6B) , demonstrating that NAPs are mediators unique to the ofloxacin pathway.
We next explored whether the mediators identified in the ampicillin pathway are active in ofloxacin persister formation. Though both mechanisms were delineated from a carbon source transition, the media conditions were different when studying the ofloxacin pathway. For ofloxacin persisters, since we discovered the presence of both a growth-arrest-dependent and a cAMPppGpp pathway, in order to study the latter, we supplemented media with trace aa to eliminate growth arrest during the carbon transition [12] . In contrast, data presented here did not suggest the presence of multiple pathways for ampicillin persister formation ( Figure 2D ), so aa-supplemented media was not required. Therefore, we tested DssrA, DsmpB, and DclpA for their role in ofloxacin persister formation in the aa-supplemented media. While DclpA exhibited persister formation similar to wild-type, DssrA and DsmpB exhibited strongly attenuated formation (Figures 6C-6E ). These results indicated that ClpA is unique to the ampicillin pathway, whereas trans-translation is an important component of both mechanisms. Since we have shown that trans-translation works through the stringent response in diauxic media, we analyzed whether DssrA in the aa-supplemented media also possesses defective stringent control by measuring ppGpp and using a transcriptional ppGpp reporter, pUA66-P wrbA -gfp [12] . Prior to ppGpp measurements, we confirmed that persister formation phenotypes in MOPS media with trace aa were analogous to those found in M9 with trace aa ( Figures  S6A-S6C) . At the transition, DclpA possessed ppGpp levels analogous to wild-type ( Figures S6D and S6E) , and after the transition, wild-type and DclpA displayed comparable induction of the ppGpp reporter in the glucose-fumarate media compared to the glucose-only control ( Figures S6F and S6G ). Similar to diauxic conditions, DssrA showed significantly lower ppGpp levels at the transition compared to wild-type ( Figures S6D and  S6E ) and exhibited no increase in fluorescence using our ppGpp reporter ( Figure S6H ), which was comparable to previous results with DrelADspoT [12] . These data demonstrated that DclpA does not influence ppGpp or the stringent response when trace aa are present, whereas DssrA affects ppGpp production and stringent transcriptional control upon the carbon source transition.
DISCUSSION
We have discovered that a single metabolic stress, carbon source transitions, initiates persister formation cascades that lead to persister heterogeneity. Here, we delineated an ampicillin persister formation pathway from source of stress, glucose exhaustion, to the activation of a RelA-dependent stringent response that required trans-translation and ClpA through a mechanism that involved DksA, which led to widespread, stringent-dependent inhibition of PGB. Common factors between the different pathways were the stringent response, building upon the growing evidence of ppGpp as a central regulator of persistence [2, 5, 12, 22, 23, 39, 40] , and trans-translation, which has recently been linked to persistence [41] . Several studies have explored the relationship between the stringent response and persistence [2, 5, 12, [22] [23] [24] 40] . Nguyen and colleagues studied biofilm persistence of Pseudomonas aeruginosa and E. coli under starvation conditions [24] , whereas Fung and colleagues analyzed the role of the stringent response in antibiotic tolerance in response to various nutrient depletions [5] . These studies not only demonstrated a role for the stringent response in persister formation due to nutritional perturbations but also provided data that the role of the stringent response in producing antibiotic tolerance is complex and likely dependent on the antibiotic's primary mode of action. In our previous work and the data presented here, we provided evidence that the stringent response signals drug-specific formation mechanisms in response to carbon source transitions. This heterogeneity can arise from the metabolite's ability to inhibit DNA replication and cell division machinery on different timescales and/or to different degrees [42] through both direct interactions and stringent transcriptional control. We found unique mediators to exist, and the concentrations of those proteins in a single cell may also play a role in survival to either ampicillin or ofloxacin. For example, a cell may possess sufficient ppGpp levels and have favorable NAP concentrations but possess an unfavorable ClpA concentration, making the cell susceptible to ampicillin but tolerant to ofloxacin. Therefore, while ppGpp and a functional stringent response are essential to formation, other factors, perhaps in combination, play a role in determining the fate of a particular cell upon antibiotic treatment.
We found that trans-translation is essential to both persister formation cascades, and it has previously been implicated in persister survival to a variety of antibiotics and stresses [41] . Our data add to this knowledge by providing evidence with direct ppGpp quantification, qPCR, and a ppGpp transcriptional reporter that trans-translation is needed for cells to exhibit normal stringent control during a carbon source transition. This requirement was an interesting discovery, and how this system exerts its effects will be the topic of a future study. (C-E) Cells were grown in aa-supplemented media and challenged with 5 mg/mL ofloxacin. DclpA (C) exhibited persister formation that was comparable to wild-type, whereas DssrA (D) and DsmpB (E) exhibited significantly reduced persister formation. Error bars indicate SEM. Significance was assessed using the null hypothesis that the mean fold change in persisters for the mutant was equal to the mean fold change in persisters for wild-type. See also Figure S6 .
Significant evidence has emerged that persisters can no longer be regarded as a homogenous multidrug-tolerant entity. The first notion of varied persister populations came from Balaban and colleagues who categorized persister cells as either type I, non-growing cells derived from stationary phase, or type II, cells that have reduced growth rates [3] . Subsequent studies analyzing persister formation in response to toxin overexpression and genetic deletions and in clinical isolates demonstrated antibiotic-dependent variability in persister levels, which suggested that activity of individual cellular processes dictated tolerance to a particular antibiotic and persister populations are not comprised of a single multidrug-tolerant population [6-8, 43, 44] . Here, we provided evidence that a single metabolic stress can generate heterogeneous subpopulations of persisters, which can present a significant therapeutic challenge. However, we demonstrated that by comparing formation pathways, shared mediators exist, and thus, a common strategy can be used to eliminate formation of different persisters. We discovered that the stringent response and transtranslation are common to both ampicillin and ofloxacin persister formation, and inhibitors of these systems are currently being explored [45, 46] .
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Culture Conditions Bacterial strains and plasmids are listed in Table S2 , and details on their construction are described in the Supplemental Experimental Procedures and Table S3 . M9 minimal medium was used in all experiments except during ppGpp quantification where MOPS minimal medium was used since phosphate concentrations need to be limited. For carbon source transition experiments, 0.5 mM glucose plus 24 mM carbon of the secondary carbon source were used. Single carbon source experiments contained 27 mM carbon. The aa supplement added to specific experiments was described previously [12] . Additional details are provided in the Supplemental Experimental Procedures.
Persistence Measurements
Persistence was measured by determining the number of colony-forming units (CFUs) per mL after exposure to 200 mg/mL ampicillin, 200 mg/mL fosfomycin, 200 mg/mL carbenicillin, 200 mg/mL cefsulodin, or 5 mg/mL ofloxacin. At specified cell densities or times, 500 mL aliquots of culture were removed, treated with antibiotic, and incubated at 37 C and 250 rpm. At the designated time point, samples were collected by centrifugation (3 min, 15,000 rpm), washed with PBS, and serially diluted in PBS, and 10 mL was spotted onto LB agar. Plates were incubated for 16 hr at 37 C and CFUs were measured. 20-100 colonies were counted for each data point unless noted otherwise.
Statistical Analysis
Statistical significance was assessed using two-tailed t tests with unequal variances. Persister data obtained from the 5 hr post-antibiotic treatment CFU/mL measurements were statistically analyzed, and the threshold for significance was set to p < 0.05.
Additional Assays
Details for experiments involving cAMP, SHX, and CAM, ppGpp quantification, qPCR, and RelA 0 overexpression are provided in the Supplemental Experimental Procedures. 
SUPPLEMENTAL INFORMATION
